Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer

20 May 2020 07:00 BST Lynparza approved in the US for HRR gene-mutatedmetastatic castration-resistant prostate cancer Only PARP inhibitor to improve overall survival vs. enzalutamide or abiraterone in a biomarker-based subset of prostate cancer patients  with BRCA1/2 or ATM mutations Approximately 20-30% of men with metastatic castration-resistant prostate cancer have an HRR gene mutation AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that Lynparza (olaparib) has been approved in the US for

Eurobattery Minerals AB hereby publishes its Interim Report January – March 2020

First quarter 2020 (same period previous year) · Net sales amounted to SEK 0 (SEK 0). · Operating income after depreciation/amortisation and financial items totalled KSEK -2,248 (KSEK -2,104) · Earnings per share after depreciation/amortisation and financial items amounted to SEK -0.23 (SEK -0.08). · Cash flow from operating activities was KSEK -1,564 (KSEK -1,564). Significant events during the period · The Company received the final assay results during the reporting period following completion of a 4 hole, 998m drill programme in the fourth quarter of 2019 at

Notice of the Annual General Meeting for Gränges AB

The Gränges AB Board of Directors has resolved to convene an annual general meeting of shareholders to be held Thursday, 25 June 2020. More detailed information about the contents of the proposals may be obtained from the complete notice to the annual general meeting below. The notice is expected to be published in the Swedish Official Gazette (Post- och Inrikes Tidningar) and on the company’s website within the next few days. English translation for information purposes only. If there are differences between the English translation and the Swedish original, the Swedish text will take

Faron Pharmaceuticals Oy Harmful association of glucocorticoids in interferon beta-1a treated patients published in Intensive Care Medicine

· Detailed analyses following INTEREST trial conclude glucocorticoids block the upregulation of CD73 in the lung capillaries and inhibit interferon signallingTURKU – FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces today that the results of its detailed analyses into the effects of glucocorticoids on intravenous (IV) interferon (IFN) beta-1a activity, which arose following the INTEREST trial in 2018, have been published in Intensive Care Medicine, a world leading journal in the field of critical care. The results

Notice of the Annual General Meeting of SinterCast AB (publ)

The shareholders of SinterCast AB (publ), reg. no. 556233-6494 (“SinterCast”) are hereby invited to participate in the Annual General Meeting to be held on Tuesday 23 June 2020, 15:00 hours, at the premises of the Royal Swedish Academy of Engineering Sciences (IVA), Grev Turegatan 16, Stockholm, Sweden. Information Related to COVID-19 In consideration of COVID-19 concerns, SinterCast encourages shareholders to not attend the Annual General Meeting. Instead, shareholders are encouraged to vote by post. Information regarding voting by post and a template for voting by post will be made

IMPROVED EARNINGS AND CONTINUED GROWTH

This is a translation of the Swedish interim report. If there should be any discrepancies, the Swedish language version governs.   FIRST QUARTER, JANUARY – MARCH 2020 ·Net sales increased by 4.7%, or 3.8% FX adjusted, to MSEK 69.4 (66.3) · Gross profit increased by 2.7%, or 1.6% FX adjusted, to MSEK 52.2 (50.9) · EBIT was MSEK -0.3 (-3.3) · Earnings after tax was MSEK 0.4 (-3.6) · Earnings per share was, basic SEK 0.06 (-0.49), diluted SEK 0.06 (-0.49)  IMPORTANT EVENTS   DURING THE PERIOD        ·P-O Westerlund was appointed as new CEO on January

OrtoWay creates new segment in spinal field with next-generation hydraulically powered OrtoWell® Distractor.

OrtoWay AB, makers of the OrtoWell® Distractor – the world’s first hydraulically powered device for spinal surgery – today announces new tool design improvements extending the clinical usage. It has also formed a new subsidiary and established manufacturing in Tuttlingen, Germany to secure world-class quality – laying a safe and solid foundation for US launch.For the first time ever, the novel device puts hydraulic power in the hands of spinal surgeons for safer, smoother, gentler and more controlled separation of vertebral bodies – ensuring high accuracy in fixation. Compared with manual

Scout Gaming publishes Q1 2020: Revenues increased 149% to mSEK 8.7

”We started the year at a high pace and maintained good momentum from the fourth quarter last year. Revenues increased by 149% to SEK 8.7 million, while all profit measures compared to corresponding quarter previous year continued to improve. In mid-March, however, like many parts of the world, we experienced an abrupt halt because of the global outbreak of COVID-19.  Since we control the entire production chain ourselves, from the technical platform, statistics, pricing to graphic design, we have succeeded in providing a competitive product even though the sports calendar has appeared

Hansa Biopharma announces upcoming presentations including a late breaking poster presentation at the 2020 American Transplant Congress

Abstract highlights · 2-year follow-up data demonstrates graft survival of 90% for 31 patients post imlifidase treatment with a median eGFR of 61.5 ml/min. Despite varying levels of DSA rebound among these imlifidase-desensitized patients, the AMR frequency was comparable with those reported in other studies with less sensitized patients.  · Reallocation of kidneys due to positive crossmatch affects the refused organ by increasing cold ischemia time and the eventual discard of kidneys. · Anti-HLA IgM antibodies are unaffected by imlifidase treatment.Lund May 20, 2020. Hansa

Changes in Gjensidige's Group Management

Gjensidige Forsikring ASA will make changes in its Group Management effective from 1 June 2020. René Fløystøl, who is in charge of E-commerce and digital channels in the Private segment, will assume the position as Executive Vice President for Private. He will replace Sigurd Austin who left the company in April this year. Tor Erik Silset will be the new EVP for Technology and Infrastructure. He will replace Kaare Østgaard, who moves to the new position as Project director with responsibility for the company’s group projects. Tor Erik Silset comes from the position as leader of

Notice to Annual General Meeting in Hansa Biopharma AB (publ)

Hansa Biopharma AB (publ), Reg. No. 556734-5359, with registered office in Lund, summons to Annual General Meeting on Tuesday June 23, 2020 at 15:00 CEST at the Elite Hotel Ideon, Scheelevägen 27, SE-223 63 Lund, Sweden. Registration will begin at 14:00 CEST and will end when the meeting starts.Lund May 20, 2020. Information in relation to the Corona virus (COVID-19) In view of the recent developments of the spread of the Corona virus (COVID-19), Hansa Biopharma has taken certain precautionary measures in relation to the Annual General Meeting on June 23, 2020. The measures are being

Dynamic quarter with increasing momentum

Net Gaming Europe AB (publ) had a stable quarter, in which we gradually increased productivity. Refinancing has been secured after the end of the quarter, giving the Company scope to continue to develop the business with a focus on profitable organic growth.First quarter 2020 · Revenue amounted to EUR 3,191 (4,053) thousand. · EBITDA amounted to EUR 1,742 (2,553) thousand. · Profit after tax was EUR 2,759 (1,941) thousand.  · Earnings per share after dilution amounted to EUR 0.036 (0.026). · New Depositing Customers (NDC) declined by -16% (-15%). · Cash flow from

INTERIM REPORT JAN-MAR 2020 (IN SWEDISH)

Oboya Horticulture Industries AB (”Oboya” or “Company”) publishes the annual report for 2019. The first quarter shows that the Company is on the right track with less headcount and decreased interest bearing liabilities.SÄRSKILDA FINANSIELLA NYCKELTAL (JANUARI-MARS 2020) · Rörelseresultat före avskrivningar (EBITDA) uppgick till 4,9 (9,8) MSEK, motsvarande 5,0% av försäljningen, exklusive avyttrade verksamheter. · Räntebärande skulder i slutet av perioden uppgick till 157,2 (199,7) MSEK, en minskning med 21% jämfört med samma tidpunkt föregående år. · Resultatet belastas med

Polygiene proposed in all Marzotto group collections

Marzotto Group in Italy, will partner with Polygiene - the global leader in stays fresh technologies, to “relaunch” the fashion industry with ViralOff application on their natural fiber textiles, such as wool, linen and cotton.   Since 1836, Marzotto Group, with a turnover of more than EUR 450 millions, is a key international player in the textile industry and is structured as a “company network” of prestigious brands. These brands are in turn sold to a majority of the most prominent fashion brands in the world. Marzotto group and Polygiene® now partner up to relaunch the fashion

Nordic Nanovector ASA: Notice of Annual General Meeting on 10 June 2020

Oslo, Norway, 20 May 2020 Notice is given that the Annual General Meeting of Nordic Nanovector ASA will be held on 10 June 2020, at 10:00 hours CEST at Thon Hotel Slottsparken, Wergelandsveien 5 in Oslo. Due to the restrictions caused by COVID-19 and the advice from the Norwegian government in connection therewith, all shareholders are encouraged to exercise their shareholder rights without physical attendance at the general meeting, either through advance electronically voting through VPS Investor Services or by using the enclosed proxy form to provide proxy to the Chairman Jan

Panoro Energy (Oslo Ticker: PEN) - Invitation to First Quarter results webinar 28 May 2020

Panoro Energy’s Q1 2020 report will be published on Thursday, 28 May 2020 and will be available on our website http://www.panoroenergy.com at 07:30 a.m. CET. The Company will hold a live webinar presentation of the 1Q results at 09:00 a.m. CET on Thursday 28 May 2020, during which management will discuss the results and operations of the first quarter. After conclusion of the discussion, participants will be invited to ask questions on the Q1 report. The webinar presentation can be accessed through registering at the link below and the online access to the event will be equipped with

Väderstad launches a new innovative stop wheel for the Tempo planter

To increase planting performance even further, Väderstad introduces the new unique stop wheel Väderstad ProStop. Thanks to its innovative design, ProStop delivers an excellent seed-to-soil contact at very high planting speed.The new stop wheel Väderstad ProStop is designed with rubber spokes to absorb external pressure in its core. Thereby the precise profile of the stop wheel is not impacted when running in the seed furrow. - The new Väderstad ProStop stop wheel is designed to flex in its core. This means that the contact between the stop wheel and the seed is never affected. ProStop

Richard Hausmann, Elekta CEO, named "Best MedTech CEO"

Elekta leader recognized for vision and integrity with 2020 MedTech Breakthrough AwardSTOCKHOLM, May 20, 2020 – Elekta (EKTA-B.ST) today announced that its President and CEO, Dr. Richard Hausmann has been recognized as the "Best MedTech CEO" by MedTech Breakthrough , an independent organization that recognizes the top companies, technologies, and products in the global health and medical technology market. Dr. Hausmann has taken bold steps to transform radiation oncology. One of these was the successful expansion of Elekta Unity, the world’s first

Nordic Nanovector ASA Announces Proposed Change of the Nomination Committee

NANO - Notice of AGM 2020  Oslo, Norway, 20 May 2020Nordic Nanovector ASA (OSE: NANO) announces that its Nomination Committee has nominated Mr. Pål Erik Robinson for election as a member of the Nomination Committee at the Company's upcoming Annual General Meeting, as Mr. Olav Steinnes, who has served as a member of the Nomination Committee since November 2014, has decided not to stand for re-election. Mr. Robinson has for the last 18 years been owner and managing director of RO Invest AS. RO Invest AS is a private

The Board of Directors of Green Landscaping resolves on a rights issue of approximately SEK 150 million

The information in this press release is not intended for publication, public release or distribution, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zeeland, Switzerland, Singapore, South Africa or any other jurisdiction where such publication or distribution would violate applicable laws or regulations. See the section “Important information” at the end of this press release.On February 21, 2020, Green Landscaping Group AB (publ) ("Green Landscaping" or "the Company") announced the acquisition of GAST Entreprenør AS ("Gast Entreprenør")

Scandic’s interim report Q1 2020 – Substantial cost reductions & secured financing

First quarter in summary · Net sales dropped 17.8% to 3,343 MSEK (4,066). · Net sales grew in January and February but fell dramatically in March due to extremely low levels of activity as a result of the spread of the coronavirus. · Extensive measures taken to lower cost levels including furlough and terminations of employees.  · Adjusted EBITDA amounted to -174 MSEK (160). Implemented cost reductions helped mitigate the negative effect of low occupancy levels in March. · Expenses affecting comparability, mainly related to staffing reductions in the company’s Swedish

Elixia fitness centre to open in the shopping centre Lippulaiva in spring 2022

CITYCON OYJ Corporate Press Release 20 May 2020When it reopens in spring 2022, the shopping centre Lippulaiva will offer much more than just shopping. It will also provide a wide range of services, bringing convenience to day-to-day life. Citycon has now further strengthened its offering by signing a lease with the Elixia fitness centre of the SATS fitness club chain. This modern fitness centre will cover approximately 1,400 square metres on the third floor of the shopping centre next to the Espoonlahti regional library. There will be facilities for cardio training and group exercise

Veidekke ASA: To renovate and extend Lillholmsskolan in Stockholm

Veidekke has been commissioned by SISAB to renovate and extend Lillholmsskolan in Skärholmen, Stockholm. The project is an execution contract with a contract sum of approx. SEK 180 million, with planned completion in the spring of 2022.“We look forward to collaborating on this exciting project, to the benefit of activities at Lillholmsskolan, says Jenny Skagstedt, project manager at SISAB – Skolfastigheter i Stockholm AB. The execution contract entails the construction of two new school buildings and the associated school yard as well as a minor renovation of an existing building. School

Wulff Group Plc: Manager Transaction - Heikki Vienola

MANAGERS’ TRANSACTIONS  MAY 20, 2020 AT 8.00 A.M.  Wulff Group Plc has received a notification from Heikki Vienola, Wulff Group Plc’s Member of the Senior Advisory Board and Growth Expert, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Person subject to thenotification requirementName: BVI-Tuote Oy, Legal personPosition: Closely associated personPerson dischargingmanagerial responsibilitiesin issuerName:

There are no items matching the current filter
There are no more items matching the current filter
Back to top